Recent interest in the metabolism of glucuronic acid has been aroused mainly as a result of the realization (1) that the conjugation of glucuronic acid is an important step in the metabolism of estrogenic and steroid hormones (2, 3) and of epinephrine (4) and following the reports that glucuronic acid may be useful in arthritis (5) . Although the mechanism of formation of glucuronides has been observed chiefly in studies of drug metabolism and has been widely accepted as a process of detoxication, the view is now prevalent (6, 7, 8) that this reaction represents a physiological process which we consider a "metabolic conjugation" (1) . Thus, it is believed that exogenous drugs are conjugated with glucuronic acid only by virtue of certain of their chemical groupings (phenolic or alcoholic hydroxyl radicals), characteristic of the endogenous metabolites which are physiologically conjugated with glucuronic acid.
In the past, studies on glucuronic acid metabolism have been carried out almost exclusively in animals and usually in these investigations the conjugated glucuronide was isolated or determinations of urinary glucuronic acid were made (9) . It is obvious that determinations of glucuronic acid in blood values would be of great value not only in animal studies but also in investigations performed in man. Accordingly, a combination of blood and urine data on glucuronic acid was considered to be necessary in any study designed to evaluate the physiological significance of glucuronic acid.
The present paper is divided into three sections. The first deals with the description of the method for determining glucuronic acid and its clinical application. The second concerns the development of a glucuronic acid tolerance test in humans, and the third describes some clinical observations relating glucuronic acid and f.-glucuronidase to arthritis and cancer of the breast.
SECTION I. DETERMINATION OF GLU-CURONIC ACID IN BLOOD AND URINE
The available methods for determining blood glucuronic acid were found to be unsuited for the purpose which we had in mind, i.e., the performance of as many as 100 determinations a day with reasonable accuracy. In 1943, Ratish and Bullowa (10) adapted the method of Maughan, Evelyn and Browne ( 11 ) for urinary glucuronic acid to the determination of glucuronic acid 3 in blood. An aliquot of a tungstic acid filtrate of blood was heated with a mixture of naphthoresorcinol and hydrochloric acid for 45 minutes. After cooling, the violet pigment was extracted, using a mixture of alcohol and ether, and the optical density of the ether layer read at 565 miu in a photoelectric colorimeter. The per cent error ranged from -11 to + 21.2. The procedure of Deichmann (12) in 1946 was performed on plasma (without deproteinization) with the naphthoresorcinol reagent, utilizing a heating period of two hours and extraction of the pigment with ether alone. Although as a rule satisfactory recoveries of glucuronic acid were obtained when it was added to plasma, frequently these were as low as 20 to 30 per cent. The use of 3 The possibility toat the naphthoresorcinol reaction may measure galacturonic acid as well as glucuronic acid has been pointed out by Deichrrann and Dierker (12) . However, in view of the fact that galacturonic acid has not yet been identified as a normal constituent of human blood and urine, it is permissible to consider the naphthoresorcinol reaction applied to protein-free filtrates of blood as one measuring essentially glucuronic acid.
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ether in these procedures has the following disadvantages: rapid evaporation, especially in the summer, a strict requirement of purification and dehydration (10, 11) , instability upon exposure to sunlight (12) , and the presence of a serious fire hazard.
It was found possible to combine the best features of the available methods and to substitute toluene for ether as the solvent for extracting the colored product of the naphthoresorcinol-glucuronic acid reaction. In this manner, a procedure has been developed which is reasonably accurate and reliable, and possesses the advantage of convenience and safety. 4 These may be purchased from Macalaster Bicknell Co., Cambridge, Mass. The following washing procedure was found necessary: the tubes were rinsed thoroughly after the analysis with alcohol and tap water before being placed in cleaning solution. The use of a wax pencil for marking these tubes is prohibited, since any wax which finds its way into the boiling tubes will dissolve in the toluene and give undesirable colored solutions. Marking with a lead pencil on a ground glass spot on these tubes is permissible.
for 10-15 minutes. After cooling, 5 cc. of 95 per cent alcohol were added to each tube, after which they were shaken to dissolve the pigment produced during the heating reaction. Then, 8 cc. of toluene were added and the tubes restoppered and vigorously shaken for one minute, this time to extract the violet pigment into the toluene phase. The aqueous layer was removed completely by suction, using a tube drawn out to a capillary attached to an aspirator and a collecting bottle. The toluene extracts were then transferred carefully to clean Evelyn cuvettes. After allowing them to stand 45 minutes in the dark to permit the extracts to clear, the transmission of light was measured in the Evelyn photoelectric colorimeter at 565 my using the 6 cc. well.
(b) Urine. Usually a 1 to 50 dilution of the urine was prepared with water. In urine rich in glucuronic acid a 1 to 100 dilution was employed. The Recovery of glucuronic acid added to blood and urine. In Table I are listed the recoveries of pure glucuronic acid added to whole blood and urine. In the upper range of blood glucuronic acid levels (8.9-11.1), the standard error was 7.3 per cent (range -7 to + 14) and for all the recovery experiments, the standard error was 8 per cent (range -20 to + 14). This performance of the method is similar to that of the method of Ratish and Bullowa (10) .
Distribution of blood glucuronic acid values in health and in some disease states. In Figure 3 is illustrated the distribution of blood glucuronic acid in 100 normal individuals and in two groups of patients, one with arthritis and the other with cancer of the breast. In Table II When studying the metabolism of any substance, it has been found useful to obtain some measure of the degree of utilization of the substance by the body. Accordingly, it was considered worthwhile to develop a tolerance test for glucuronic acid in humans in order to study the utilization of glucuronic acid and factors which may influence its metabolism.
Employing the method for blood glucuronic acid described in the first section of this paper, blood levels of glucuronic acid were determined before, and at intervals after, oral administration of glucurenolactone. It was found that only a small proportion of this substance was excreted in the urine. Glucuronic acid tolerance curves were then obtained on 17 normal subjects, on 12 patients with arthritis and on 10 patients with various types of cancer. A description of the technique for per- In all of the tolerance tests, P-glucuronidase activity of blood serum was determined simultaneously (14) and a typical result, illustrating the behavior of blood glucuronic acid and P-glucuronidase activity, is shown in Figure 6 .
RESULTS
All of the normal subjects (Figure 4 ) exhibited an elevation in blood glucuronic acid following the ingestion of 5 grams of glucurone which appeared within 30 to 60 minutes and which persisted for as long as four hours. However, by six hours, in the majority of cases, the blood glucuronic acid levels had returned to the pre-ingestion level. In five subjects, two peaks in the curve were noted. A composite curve of these data is shown in Figure 5 .
Arthritis (Figure 7) . Five of 12 arthritic patients showed abnormal curves in which the level at six hours was as high as or higher than the peak elevation; the curves in the remainder appeared essentially normal.
Cancer ( Figure 8 ). Four patients with carcinoma of the rectum exhibited abnormal, flat or retention curves. Two subjects with cancer of the lung, and one with cancer of the thyroid showed accentuated declines in their blood glucuronic acid levels after the peak had been reached. One zyme would be depleted) or 3) the glucuronic acid may cause blood f-glucuronidase to be removed from the blood for some as yet unknown purpose. As indicated in Table IV , there is no inhibition of serum fB-glucuronidase in experiments where glucuronic acid is added in vitro in amounts corresponding to the highest concentrations of this substance observed in our tolerance curves. It is also clear that glucuronic acid added to whole blood does not result in a shift of /8-glucuronidase from the plasma to the cells. Since little change is found in the amounts of glucurone excreted in the urine during and after the tolerance test, there seems to be little doubt that the glucurone administered orally is utilized by the human subject. It remains to be determined which organ(s) take up this glucuronic acid and in which processes of metabolism the glucurone participates.
A pattern of glucuronic acid curves is evolving with three distinct types of curves. Some of these curves appear to be characteristic of certain types of cancer and to a much lesser extent arthritis and other chronic diseases (15) .
SECTION III. OBSERVATIONS IN PATIENTS RECEIVING ANTI-ARTHRITIC AND ANTI-TUMORAL AGENTS

Arthritis
Four patients with an established diagnosis of rheumatoid arthritis were treated with ACTH, cortisone and glucurone and were studied from 70 to 150 days. All of these subjects at one or more periods in the study exhibited sudden and marked elevations in serum I8-glucuronidase and in three, the blood glucuronic acid levels fluctuated markedly. The behavior of these two blood constituents in one of these patients whose arthritis was difficult to control is illustrated in Figure 9 . In normal healthy subjects, blood glucuronic acid and serum fl-glucuronidase levels are considerably more constant.
Cancer of the breast A. Methylandrostenediol. Thirteen patients with metastatic cancer of the breast were treated for two to 18 months with methylandrostenediol, a weakly-virilizing protein anabolic steroid (16) . In three of these subjects, showing neither subjective nor objective clinical improvement, f8-glucuronidase and glucuronic acid values showed no change during the course of therapy. In 10 patients with subjective improvement, including three with objective responses, the values of these blood constituents were abnormally high at one or more times during therapy. The behavior of blood glucuronic acid and serum /3-glucuronidase levels is illustrated in one of these subjects in Figure 10 . Clinically, there appeared to be a correlation of the increased levels of either one or both of these blood constituents with the improvement observed in the patient.
B. Stilbestrol. The administration of this hormone was found to increase the blood /3-glucuronidase not only in women with cancer of the breast (17) but also in non-cancerous subjects (15) . It had been found previously (18) that stilbestrol administered for 10 days of the post-partum period will prevent to a great extent the fall in serum ,8-glucuronidase which otherwise normally occurs following parturition. The resemblance of the effects of methylandrostenediol and stilbestrol upon the /8-glucuronidase and the glucuronic acid of the blood is of interest from two points of view. First, it offers an avenue of approach to the development of chemical indices in the blood for evaluating the effect of chemo-therapeutic drugs in cancer of the breast and secondly, it suggests that in these subjects methylandrostenediol has a biochemical effect in common with stilbestrol. Origin of glucuronic acid. It is generally believed that liver glycogen is the ultimate source of glucuronic acid. Quick (19) , in 1926, showed that the administration of insulin to diabetic dogs greatly increased the output of glucuronic acid, while Kobayashi (20) , in 1934, found low glycogen content in the livers of rabbits which had been given the glucuronidogenic drug, avertin. Later, Schmid (21) reported that the tolerance to menthol was much less in hibernating frogs whose liver glycogen had been depleted and Dziewiatkowski and Lewis (22) found a 50 per cent reduction in liver glycogen four hours after administering menthol to rats.
Direct evidence that glucose can be used for the synthesis of glucuronic acid in conjugated form was reported by Mosbach and King (23) . After administering glucose labelled with C14 uniformly in all six carbons to guinea pigs which were simultaneously given borneol, the glucuronic acid of the Zn bornyl glucuronide isolated from the urine was found to contain radioactive carbon, likewise uniformly distributed amongst its six carbon atoms.
On the other hand, administered glucuronic acid is not converted into glucose, since, to take one example, Quick (24) was unable to relieve insulin convulsions in mice by the administration of glucurone.
Fate of glucuronic acid. Glucuronic acid in amounts of 3 to 10 grams is almost completely metabolized by humans (24) (25) (26) and rabbits and dogs similarly metabolize glucuronic acid (27) . Flaschentrager and colleagues (26) pletely, and borneol and its glucuronide to a great extent. Smith and Williams (28) demonstrated that the rabbit metabolized stilbestrol glucuronide. It therefore seems reasonable that the intact conjugated glucuronides may undergo metabolism.
Scheme of glucuronic acid metabolism. In the accompanying scheme ( Figure 11 ) the facts detailed above have been related. The evidence for dialyzable acid hexuronides rests on observations we have made on the nature of tissue uronides which show clearly that the dialyzable uronide of tissue is of a molecular species lower than hyaluronic acid and higher than that of the simple conjugated glucuronides. In all the pathways postulated uncertainty is indicated as to the exact mechanism. Final conclusive proof that glucuronic acid behaves in the manner outlined must await definitive studies, possibly utilizing glucuronic acid labelled with C14.
Present results. In our studies, it has been found that glucuronic acid in 5 gram amounts given orally is almost completely utilized as judged by the urinary excretion of glucuronic acid.
Glucuronic acid tolerance curves. Of interest is the rapidity with which blood glucuronic acid levels, once elevated by oral glucuronic acid, decline to normal values. It would seem that the concentration of this substance is under homeostatic control by agencies which at present are unknown. The blood sugar and phosphorus remain unchanged during the course of glucuronic acid absorption and utilization. Accordingly, the postulated homeostatic mechanism is probably unrelated to glucose metabolism and may be related to formation of pentose and furan dicarboxylic acid.
Observations in arthritis and caneer. In certain patients, e.g., those with cancer of the rectum, there appears to be a definite retention of glucuronic acid in the blood, and in others (see Figure 8) there exists a tendency for a marked decline in blood glucuronic acid. In all patients, the serum glucuronidase declined after ingestion of glucuronic acid. On the basis of the present data, no explanation can be advanced for these phenomena, nor can these phenomena be considered peculiar only for cancer and arthritis.
The lability of glucuronic acid concentration in the blood of patients with rheumatoid arthritis is interesting. It is known that glucuronic acid compounds such as hyaluronic acid and chondroitin sulfate are important constituents of cartilage and the joint capsule. The present observations raise the question whether or not arthritis may be accompanied by a disorder of glucuronic acid metabolism.
The frequent elevations of glucuronic acid seen in the blood of patients with carcinoma of the breast receiving methylandrostenediol therapy is a new observation for which no explanation is proposed.
Finally, it is found that the continuation of study in this relatively new field of investigation may help in our attempts to understand the interrelationships in metabolism of the steroid hormones, glucuronic acid and f-glucuronidase. CONCLUSIONS 1. A method for determining glucuronic acid in blood and urine has been developed by modifying existing procedures and by substituting toluene for ether in the extraction of the violet pigment produced in the naphthoresorcinol reaction. Toluene solutions of the pigment absorbed light maximally at 570-580 mu. A linear relationship was found between the optical density of toluene extracts prepared from the reaction of naphthoresorcinol with glucuronic acid in the range of concentrations employed (5 y to 40y).
Values are reported for 100 normal individuals and in a number of arthritics and patients with cancer of the breast.
2. Glucuronic acid (glucurone) administered orally appears to be utilized inasmuch as little of it is excreted in the urine. In normal subjects, a peak in the blood glucuronic acid is found within 30-60 minutes after ingestion which may persist from one to four hours. By six hours afterwards the blood glucuronic acid returned to pre-ingestion levels.
3. In five out of 12 arthritics and seven of 10 patients with cancer, these glucuronic acid tolerance curves were abnormal. Some showed what appeared to be retention of glucuronic acid in the blood while others were characterized by an unusually marked fall in glucuronic acid after the peak concentration had been passed. 4 . Serum f6-glucuronidase activity fell simultaneously with the rise in blood glucuronic acid seen in the glucuronic acid tolerance test.
5. These findings have been discussed in relation to the known facts of glucuronic acid metabolism which have been received.
